Finance

Lists
OTLC:OTCMKTS
Oncotelic Therapeutics Inc
$0.027
-2.14%
(-0.00060) 1D
Sep 16, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OTLC...
Open
$0.03
High
$0.03
Low
$0.03
Mkt. cap
11.70M
Avg. vol.
216.92K
Volume
403.57K
P/E ratio
0.05
52-wk high
$0.11
52-wk low
$0.02
EPS
$0.55
Beta
-0.24
Shares outstanding
457.51M
No. of employees
41
Open
$0.03
High
$0.03
Low
$0.03
Mkt. cap
11.70M
Avg. vol.
216.92K
Volume
403.57K
P/E ratio
0.05
52-wk high
$0.11
52-wk low
$0.02
EPS
$0.55
Beta
-0.24
Shares outstanding
457.51M
No. of employees
41
About Oncotelic Therapeutics Inc
CEO-
Employees41
Founded1988
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websiteoncotelic.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
250.00K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
426.00
3.34K
795.00
345.00
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
490.55K
2.33M
1.85M
1.09M
Operating expense
490.97K
2.33M
1.85M
1.09M
Total operating expenses
490.97K
2.33M
1.85M
1.09M
Operating income
-490.97K
-2.33M
-1.85M
-843.56K
Other non operating income
-392.06K
326.43K
-90.08K
102.87K
EBT including unusual items
-1.11M
361.84M
-2.24M
341.01K
EBT excluding unusual items
-1.11M
-2.24M
-2.24M
-1.06M
Income tax expense
-
111.55M
-
-
Effective tax rate
-
30.83%
-
-
Other operating expenses
-
-
-
-
Net income
-1.05M
250.35M
-2.19M
388.15K
Net profit margin
-
-
-
155.26%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-231.34K
-242.57K
-295.81K
-318.29K
Net interest expenses
-231.34K
-242.57K
-295.81K
-318.29K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps